Gossypol.
Research-backed compound with potential health benefits. Damages sperm-producing cells, leading to low or zero sperm count. It was researched as a non-hormonal male contraceptive pill.
Reviewed March 2026
- Category
- Compound
What Gossypol is, and what it does.
- Does it work
- No. Absolutely not for self-experimentation. Save your fertility.
- How much to take
- Do not take this. Doses in clinical trials were around 10-20mg daily, but this is irrelevant for consumers because you should not be using it.
- Time to feel it
- This is not something with a daily onset. Its documented effects on sperm output and on blood potassium develop across weeks to months and are read from lab tests.
- The first dose
- Nothing good. Maybe some initial GI upset. The dangerous effects, like your potassium dropping, can start within days to weeks.
- With regular use
- Drastically reduced sperm count after 2-3 months. That's a terrible gamble.
- How well tolerated
- Extremely unsafe for general use. It's a known toxin. The primary safety concerns are irreversible sterility and life-threatening hypokalemia. This is not a drill.
- How it feels
- Like you're slowly being poisoned. Fatigue, muscle weakness, and apathy are common signs of the potassium depletion it causes.
- The overlooked benefit
- Its two aldehyde groups latch onto lysine in protein, which is why feed analysis reports free and total gossypol as separate numbers and heat-processed meal reads lower.
10 to 20mg a day is where Gossypol works.
Source: Coutinho et al. Contraception 2002; Wu D. Contraception 1989
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Gossypol is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- Reduced sperm output in menRandomised trial
- Lowered blood potassium with continued intakeNarrative review
- Iron chelation and reduced mineral availabilityAnimal study
- Binding to lysine in dietary protein, lowering protein qualityIn vitro study
- Effects on cell growth signalling in cultured cellsIn vitro study
Questions people ask about Gossypol.
- Is this a natural male birth control?
- It's natural, but it's also a toxin. It was studied for this but largely abandoned due to a high rate of permanent sterility.
- Can I use it to lower my sperm count?
- Do not. You risk making yourself permanently infertile. There are no safe, self-administered protocols.
- Where can I buy gossypol?
- You shouldn't. It's sold as a 'research chemical' from unregulated sources. You have no idea what you're actually getting.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
The reactive aldehyde groups on gossypol form Schiff bases with the epsilon-amino group of lysine, which is the long-documented reason cottonseed protein has reduced lysine availability. Bound lysine is not released during digestion.
Free gossypol chelates iron through its ortho-hydroxyl and aldehyde groups, and added iron salts are the standard way to bind it in cottonseed feed. Each one lowers what is available from the other.
Gossypol is a binaphthyl polyphenol with strong metal-binding hydroxyls that hold nonheme iron in an unabsorbable complex. This is both the basis of iron-based mitigation in feed and a reason gossypol lowers iron availability.
Gossypol redox-cycles and generates reactive oxygen species that propagate lipid peroxidation in membranes. Alpha-tocopherol is the chain-breaking antioxidant that terminates that propagation in the lipid phase.
Reactive aldehydes and quinone-type intermediates from gossypol are handled by glutathione conjugation, which consumes the thiol pool. Gossypol exposure therefore draws down glutathione.
Calcium salts complex free gossypol in the gut in the same way iron salts do, which is why calcium hydroxide has been used in cottonseed processing. The binding is mutual, so both are less available.
Gossypol carries two reactive aldehyde groups, and free thiols react with aldehydes readily. N-acetylcysteine supplies such a thiol and also feeds cysteine into glutathione synthesis, the cell's main route for handling reactive electrophiles. The direction is a reduction in free reactive gossypol, which is why thiol compounds appear in the experimental literature around it. This is chemistry and cell-level work, not a human combination trial.
Cysteine is the sulphur-donating and rate-limiting amino acid for glutathione synthesis, and its free thiol also reacts directly with aldehydes. Gossypol's reactivity is aldehyde-driven, so cysteine availability sits directly upstream of how much of it is neutralised. The relationship is established biochemistry rather than a measured supplement pairing.
Glutathione is a tripeptide of glutamate, cysteine and glycine, so glycine supply is structurally required for it to be made. Since glutathione conjugation is the general route for handling reactive electrophiles such as gossypol's aldehyde groups, glycine sits in the supporting position rather than acting on gossypol directly. Cysteine is normally the limiting one of the three.
Methionine feeds the transsulphuration pathway through homocysteine and cystathionine to produce cysteine, which is the limiting input to glutathione. That places methionine two steps upstream of the thiol pool that handles reactive aldehyde chemistry. The route requires vitamin B6 as the cofactor at the cystathionine steps.
Gossypol's ortho-hydroxy aldehyde arrangement chelates divalent and trivalent metal cations, which is the same structural feature behind its well-documented binding of iron. Copper is bound by comparable ligand chemistry. Where gossypol is present in a feed or matrix, mineral availability is the parameter to watch.
Selenium is the catalytic atom in glutathione peroxidase, the enzyme that clears hydroperoxides using glutathione as its reducing substrate. That places selenium alongside vitamin E and the thiol pool in the antioxidant defences that experimental work on gossypol exposure repeatedly measures. The pairing is nutritional context around a research compound, not a supplement recommendation.
Dihydrolipoic acid carries two thiol groups and participates in cellular thiol redox cycling. That chemistry is the same class that reacts with aldehyde-bearing electrophiles. The connection is mechanistic rather than measured for this compound specifically.
Gossypol's aldehyde groups form Schiff bases with the epsilon-amino group of protein-bound lysine, converting free gossypol into the bound form that is far less available. This is exactly why feed analysis reports free and total gossypol as separate numbers. Any lysine-rich protein source present in the same matrix shifts that balance toward the bound fraction.
An animal study reported that a Lactiplantibacillus plantarum strain shifted intestinal microbiota composition and lessened gossypol-associated elevated liver fat in the model used. The route described runs through the gut microbial community rather than through direct chemical binding. This is a non-human finding in one model and does not carry over to people without further work.
The microbiota-mediated route reported for a single Lactiplantibacillus strain is the only probiotic evidence attached to this compound, and it was measured in animals. Generalising from one strain to the probiotic category is not supported. The row exists so the strain-specificity is on the record.
Pyridoxal-5-phosphate is the cofactor for cystathionine beta-synthase and cystathionine gamma-lyase, the two enzymes that convert homocysteine into cysteine. Without it the methionine route to cysteine and then glutathione does not run. That places B6 upstream of the thiol defences relevant to reactive aldehyde chemistry.
Nothing specific on file for Gossypol. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Gossypol actually does.
Gossypol is a polyphenolic binaphthyl dialdehyde produced in the pigment glands of Gossypium (cotton) seed, where it functions as a plant defence compound.
Its two reactive aldehyde groups condense with primary amines, most notably the epsilon-amino group of lysine, to form Schiff bases; this reaction is what converts free gossypol into bound gossypol.
Feed and ingredient analysis therefore reports free gossypol and total gossypol as two different numbers, because only the free fraction carries the reactive chemistry.
Heat and moisture during oilseed processing drive the binding reaction with protein lysine, which is why expeller and solvent-extracted meals differ in free gossypol content from the raw seed.
Where Gossypol comes from.
It is a yellow compound the cotton plant makes inside tiny glands in its seeds, as a natural defence. When cottonseed is crushed for oil, most of it sticks to the protein in the leftover meal; what stays loose can be pulled out with solvent and crystallised in a lab. It is not made as a supplement ingredient and is not sold as one.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Gossypol accumulates in the pigment glands of Gossypium seed. Glandless cotton varieties were bred specifically to lack those glands and therefore carry very little of it, which is the agronomic route to a low-gossypol meal.
Seed is delinted, dehulled and pressed or solvent-extracted for oil. Heat and moisture in this step drive gossypol into Schiff base adducts with meal protein lysine, which is why free gossypol in the meal is lower than in the raw seed and why processing conditions determine the figure.
For isolation, the meal is extracted with organic solvent such as acetone or diethyl ether, which pulls the free fraction into solution.
The crude extract is crystallised from acetic acid to give gossypol acetic acid, the standard purified solid. Single atropisomers require a further chiral resolution step.
Free gossypol and total gossypol are quantified separately, since the two describe different things. Regulatory feed limits are written against the free figure.
The purified compound is supplied for laboratory use. It is not manufactured, marketed or sold as a dietary supplement ingredient, and its presence in the food chain is as a residual constituent of cottonseed feed materials rather than as an added ingredient.
Getting Gossypol from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Among men taking gossypol daily, sperm production fell sharply during treatment, and recovery after stopping was slow and in some participants incomplete.Cohort study. Liu et al., 1987 (American journal of obstetrics and gynecology). PMID 3314523 ↗
- A share of men taking gossypol developed low blood potassium, some with muscle weakness, which the authors flagged as the main limiting effect.Cohort study. Liu et al., 1987 (Fertility and sterility). PMID 3305088 ↗
- Giving a potassium salt or a potassium-sparing agent alongside gossypol reduced the fall in blood potassium seen in treated men.Randomised trial. Liu et al., 1988 (Contraception). PMID 3370986 ↗
- The frequency of free gossypol supplementation was examined against reproductive toxicity measures in young bulls, with the dosing schedule itself treated as the variable.Animal study. Hatamoto-Zervoudakis et al., 2018 (Theriogenology). PMID 29407896 ↗
- Milk production and plasma gossypol concentrations were compared in cows fed cottonseed and other oilseed meals with or without rumen-undegradable protein, linking dietary source to the circulating gossypol figure.Animal study. Blackwelder et al., 1998 (Journal of Dairy Science). PMID 9839237 ↗
- A Lactiplantibacillus plantarum intervention lessened gossypol-associated elevated liver fat in the model used, and the authors attribute the effect to a shift in intestinal microbiota rather than to direct binding.Animal study. Ding et al., 2025 (Microbiome). PMID 40759977 ↗
- Alpha-tocopherol effects on metmyoglobin formation and reduction were measured in beef from cattle fed soybean or cottonseed meal, with gossypol named as a constituent of the cottonseed diet rather than as the tested agent.Animal study. Chan et al., 1998 (Journal of Animal Science). PMID 9621948 ↗
- Whole cottonseed with palmitic and oleic acid supplementation was evaluated for production responses in the immediate post-calving period; gossypol appears as a constituent of the cottonseed feed rather than as an isolated variable.Animal study. Parales-Giron et al., 2026 (Journal of Dairy Science). PMID 41207435 ↗
- The review positions cottonseed protein as an under-used non-grain protein source for aquafeed and discusses gossypol content as the constraint that processing has to address.Narrative review. Wang et al., 2026 (Animal Nutrition). PMID 41716832 ↗
- Morinda officinalis oligosaccharides were reported to improve sperm motility through gut microbiota and IGF-related signalling in the model studied; gossypol is named within the report rather than being the intervention.Animal study. Hu et al., 2025 (Frontiers in Endocrinology). PMID 41561043 ↗
These are the studies our verdict leans on, chosen from the 500 we read for Gossypol. The full linked list is below.
The studies, linked.
10 sources behind our Gossypol verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialA Phase 2 Study of R-(-)-Gossypol (Ascenta's AT-101) in Recurrent Glioblastoma MultiformeClinicalTrials.gov ↗PHASE2 · 56 participants · Completed
- Clinical trialA Phase I, Open Label Study of AT-101 Plus Radiotherapy and Temozolomide and of AT-101 Plus Adjuvant Temozolomide for Patients With Newly-Diagnosed Glioblastoma MultiformeClinicalTrials.gov ↗PHASE1 · 50 participants · Completed
- Clinical trialA Phase 1 Study of R-(-)-Gossypol (Ascenta's AT-101) in Combination With Paclitaxel and Carboplatin in Solid TumorsClinicalTrials.gov ↗PHASE1 · 36 participants · Completed
- Clinical trialA Phase 1 Study of R-(-)-Gossypol (AT-101) in Combination With Cisplatin and Etoposide in Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung CancerClinicalTrials.gov ↗PHASE1 · 27 participants · Completed
- Clinical trialA Phase II Study of AT-101 in Recurrent Extensive Stage Small Cell Lung CancerClinicalTrials.gov ↗PHASE2 · 15 participants · Completed
- Clinical trialA Phase I/II Clinical Trial of Lenalidomide in Combination With AT-101 for the Treatment of Relapsed B-Cell Chronic Lymphocytic Leukemia (B-CLL)ClinicalTrials.gov ↗PHASE1 · 5 participants · Terminated
- Clinical trialA Randomized, Double Blind, Placebo-controlled Multiple-center Phase III Trial of Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High ExpressionClinicalTrials.gov ↗PHASE3 · 204 participants · Unknown
- Clinical trialExplore the Efficacy and Safety of Dalpiciclib Combined With Fluvestrant and Compound Gossypol Acetate Tablets in Advanced HR-positive and HER2-negative Breast Cancer After CDK4/6 Treatment Failed.ClinicalTrials.gov ↗PHASE2 · 53 participants · Unknown
- Clinical trialA Single-Arm, Open-Label, Exploratory Phase II Clinical Trial of Sintilimab Plus Gossypol Acetate in Patients With Advanced pMMR/MSS Colorectal Cancer After Failure of at Least Two Prior Lines of TherapyClinicalTrials.gov ↗PHASE2 · 32 participants · Not yet recruiting
- Clinical trialGossypol Acetate Combined With Bevacizumab and FOLFIRI as Second-Line Therapy for Metastatic Colorectal Cancer With TP53 Mutation and LRPPRC Positivity: A Single-Center, Single-Arm Clinical StudyClinicalTrials.gov ↗PHASE2 · 20 participants · Not yet recruiting
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 33 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Gossypol is, not how risky it is. A report is not proof Gossypol caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.